"10.1371_journal.pone.0096955","plos one","2014-05-09T00:00:00Z","Esther Nkuipou-Kenfack; Flore Duranton; Nathalie Gayrard; Àngel Argilés; Ulrika Lundin; Klaus M Weinberger; Mohammed Dakna; Christian Delles; William Mullen; Holger Husi; Julie Klein; Thomas Koeck; Petra Zürbig; Harald Mischak","Mosaiques Diagnostics GmbH, Hannover, Germany; Department of Toxicology, Hannover Medical School, Hannover, Germany; RD Néphrologie, Montpellier, France; Biocrates life sciences AG, Innsbruck, Austria; sAnalytiCo Ltd, Belfast, United Kingdom; Department of Biomedical Informatics and Mechatronics, Private University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria; Néphrologie Dialyse St Guilhem, Séte, France; Service de Néphrologie, Dialyse Péritonéale et Transplantation, Montpellier, France; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: ENK AA HM KW. Performed the experiments: WM NG UL KW. Analyzed the data: MD ENK JK HH PZ TK HM FD AA UL KW. Contributed reagents/materials/analysis tools: HM AA KW. Wrote the paper: ENK HM JK TK CD PZ AA FD MD KW.","H. Mischak is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology for clinical application. E. Nkuipou-Kenfack, M. Dakna, J. Klein, T. Koeck, and P. Zürbig are employees of Mosaiques Diagnostics. U. Lundin was an employee of Biocrates Life Sciences AG. K. Weinberger is a shareholder and consultant of Biocrates Life Sciences AG, who developed the metabolomics platform and kit products for research and diagnostic applications. These issues do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","05","Esther Nkuipou-Kenfack","ENK",14,TRUE,4,4,11,10,TRUE,TRUE,TRUE,1,"4",FALSE
